1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Osteoporosis Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Bisphosphonates
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Calcitonin
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Rank Ligand Inhibitor
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Parathyroid Hormone Therapy (PTH)
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Selective Estrogen Receptor Modulators (SERMs)
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Sclerostin Inhibitor
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Injectable
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Amgen Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Eli Lilly and Company
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 F. Hoffmann-La Roche AG
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 SWOT Analysis
13.3.4 GlaxoSmithKline Plc
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Merck & Co. Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Novartis AG
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Pfizer Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Radius Health Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.9 Teva Pharmaceutical Industries Ltd.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 UCB S.A.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
Figure 2: Global: Osteoporosis Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Osteoporosis Drugs Market: Breakup by Product Type (in %), 2022
Figure 4: Global: Osteoporosis Drugs Market: Breakup by Route of Administration (in %), 2022
Figure 5: Global: Osteoporosis Drugs Market: Breakup by Region (in %), 2022
Figure 6: Global: Osteoporosis Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 7: Global: Osteoporosis Drugs (Bisphosphonates) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Osteoporosis Drugs (Bisphosphonates) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Osteoporosis Drugs (Calcitonin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Osteoporosis Drugs (Calcitonin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Osteoporosis Drugs (Rank Ligand Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Osteoporosis Drugs (Rank Ligand Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Osteoporosis Drugs (Parathyroid Hormone Therapy- PTH) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Osteoporosis Drugs (Parathyroid Hormone Therapy- PTH) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Osteoporosis Drugs (Selective Estrogen Receptor Modulators- SERMs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Osteoporosis Drugs (Selective Estrogen Receptor Modulators- SERMs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Osteoporosis Drugs (Sclerostin Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Osteoporosis Drugs (Sclerostin Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Osteoporosis Drugs (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Osteoporosis Drugs (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Osteoporosis Drugs (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Osteoporosis Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Osteoporosis Drugs (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Osteoporosis Drugs (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Osteoporosis Drugs (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Osteoporosis Drugs (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: North America: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: North America: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: United States: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: United States: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Canada: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Canada: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Asia-Pacific: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Asia-Pacific: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: China: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: China: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Japan: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Japan: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: India: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: India: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: South Korea: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: South Korea: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Australia: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Australia: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Indonesia: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Indonesia: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Others: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Others: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Europe: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Europe: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Germany: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Germany: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: France: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: France: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: United Kingdom: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: United Kingdom: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Italy: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Italy: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Spain: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Spain: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Russia: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Russia: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Others: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Others: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Latin America: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Latin America: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Brazil: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Brazil: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Mexico: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Mexico: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Others: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Others: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Middle East and Africa: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Middle East and Africa: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Middle East and Africa: Osteoporosis Drugs Market: Breakup by Country (in %), 2022
Figure 76: Global: Osteoporosis Drugs Industry: SWOT Analysis
Figure 77: Global: Osteoporosis Drugs Industry: Value Chain Analysis
Figure 78: Global: Osteoporosis Drugs Industry: Porter's Five Forces Analysis
Table 1: Global: Osteoporosis Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Osteoporosis Drugs Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Osteoporosis Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 4: Global: Osteoporosis Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Osteoporosis Drugs Market: Competitive Structure
Table 6: Global: Osteoporosis Drugs Market: Key Players
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
